These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23048186)

  • 21. Melanocortin-4 receptor agonists for the treatment of obesity.
    Emmerson PJ; Fisher MJ; Yan LZ; Mayer JP
    Curr Top Med Chem; 2007; 7(11):1121-30. PubMed ID: 17584132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibition reduces food intake and weight gain and improves glucose tolerance in melanocortin-4 receptor deficient female rats.
    Mul JD; Seeley RJ; Woods SC; Begg DP
    Physiol Behav; 2013 Sep; 121():43-8. PubMed ID: 23416175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
    Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
    Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse models for V103I and I251L gain of function variants of the human MC4R display decreased adiposity but are not protected against a hypercaloric diet.
    Rojo D; McCarthy C; Raingo J; Rubinstein M
    Mol Metab; 2020 Dec; 42():101077. PubMed ID: 32916307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity.
    Phan LK; Chung WK; Leibel RL
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E611-20. PubMed ID: 16638826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
    Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
    Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.
    Yeo GSH; Chao DHM; Siegert AM; Koerperich ZM; Ericson MD; Simonds SE; Larson CM; Luquet S; Clarke I; Sharma S; Clément K; Cowley MA; Haskell-Luevano C; Van Der Ploeg L; Adan RAH
    Mol Metab; 2021 Jun; 48():101206. PubMed ID: 33684608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a novel MC4R agonist on maintenance of reduced body weight in diet-induced obese mice.
    Skowronski AA; Morabito MV; Mueller BR; Lee S; Hjorth S; Lehmann A; Watanabe K; Zeltser LM; Ravussin Y; Rosenbaum M; LeDuc CA; Leibel RL
    Obesity (Silver Spring); 2014 May; 22(5):1287-95. PubMed ID: 24318934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celastrol Reduces Obesity in MC4R Deficiency and Stimulates Sympathetic Nerve Activity Affecting Metabolic and Cardiovascular Functions.
    Saito K; Davis KC; Morgan DA; Toth BA; Jiang J; Singh U; Berglund ED; Grobe JL; Rahmouni K; Cui H
    Diabetes; 2019 Jun; 68(6):1210-1220. PubMed ID: 30894367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lorcaserin improves glycemic control via a melanocortin neurocircuit.
    Burke LK; Ogunnowo-Bada E; Georgescu T; Cristiano C; de Morentin PBM; Valencia Torres L; D'Agostino G; Riches C; Heeley N; Ruan Y; Rubinstein M; Low MJ; Myers MG; Rochford JJ; Evans ML; Heisler LK
    Mol Metab; 2017 Oct; 6(10):1092-1102. PubMed ID: 29031711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling.
    Israeli H; Degtjarik O; Fierro F; Chunilal V; Gill AK; Roth NJ; Botta J; Prabahar V; Peleg Y; Chan LF; Ben-Zvi D; McCormick PJ; Niv MY; Shalev-Benami M
    Science; 2021 May; 372(6544):808-814. PubMed ID: 33858992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function.
    Nicholson JR; Peter JC; Lecourt AC; Barde YA; Hofbauer KG
    J Neuroendocrinol; 2007 Dec; 19(12):974-82. PubMed ID: 18001327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.
    Nargund RP; Strack AM; Fong TM
    J Med Chem; 2006 Jul; 49(14):4035-43. PubMed ID: 16821763
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.
    Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of voluntary ethanol consumption and the effects of a melanocortin (MC) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor.
    Navarro M; Lerma-Cabrera JM; Carvajal F; Lowery EG; Cubero I; Thiele TE
    Alcohol Clin Exp Res; 2011 Jun; 35(6):1058-66. PubMed ID: 21332528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of melanocortin 4 receptor (MC4R) mutations and polymorphismsin consecutively ascertained obese children and adolescents from a pediatric health care utilization population].
    Zakel UA; Wudy SA; Heinzel-Gutenbrunner M; Görg T; Schäfer H; Gortner L; Blum WF; Hebebrand J; Hinney A
    Klin Padiatr; 2005; 217(4):244-9. PubMed ID: 16032553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.
    Iepsen EW; Zhang J; Thomsen HS; Hansen EL; Hollensted M; Madsbad S; Hansen T; Holst JJ; Holm JC; Torekov SS
    Cell Metab; 2018 Jul; 28(1):23-32.e3. PubMed ID: 29861388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity.
    He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Weinberg DH; Macneil T; Tang R; Strack AM; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4399-405. PubMed ID: 20598882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.